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Abstract
Background  and  objectives:  Even  a  small  amount  of  bleeding  during  endoscopic  sinus  surgery
can corrupt  the  endoscopic  ﬁeld  and  complicate  the  procedure.  Various  techniques,  including
induced  hypotension,  can  minimize  bleeding  during  endoscopic  sinus  surgery.  The  aim  of  this
study  was  to  compare  the  surgical  vision  quality,  haemodynamic  parameters,  postoperative
pain,  and  other  effects  of  magnesium,  a  hypotensive  agent,  with  that  of  dexmedetomidine,
which was  initially  developed  for  short-term  sedation  in  the  intensive  care  unit  but  also  is  an
alpha  2  agonist  sedative.
Method: 60  patients  between  the  ages  of  18  and  45  years  were  divided  into  either  the  mag-
nesium group  (Group  M)  or  the  dexmedetomidine  group  (Group  D).  In  Group  M,  magnesium
sulphate  was  given  at  a  pre-induction  loading  dose  of  50  mg  kg−1 over  10  min  and  maintained
at 15  mg  kg−1 h−1;  in  Group  D,  dexmedetomidine  was  given  at  1  mcg  kg−1 10  min  before  induc-
tion and  maintained  at  0.6  mcg  kg−1 h−1.  Intraoperatively,  the  haemodynamic  and  respiratory
parameters  and  6-point  intraoperative  surgical  ﬁeld  evaluation  scale  were  recorded.  During
the  postoperative  period,  an  11-point  numerical  pain  scale,  the  Ramsay  sedation  scale,  the
nausea/vomiting  scale,  the  adverse  effects  proﬁle,  and  itching  parameters  were  noted.
Results: Group  D  showed  a  signiﬁcant  decrease  in  intraoperative  surgical  ﬁeld  evaluation  scale
scale  score  and  heart  rate.  The  average  operation  time  was  50  min,  and  Group  M  had  a  higher
number  of  prolonged  surgeries.  No  signiﬁcant  difference  was  found  in  the  other  parameters.
Conclusions:  Due  to  its  reduction  of  bleeding  and  heart  rate  in  endoscopic  sinus  surgery  and
its positive  impacts  on  the  duration  of  surgery,  we  consider  dexmedetomidine  to  be  a  good
alternative  to  magnesium.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  
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PALAVRAS-CHAVE
Cirurgia  endoscópica
sinusal;
Sulfato  de  Magnésio;
Dexmedetomidina;
Hipotensão
Comparac¸ão  dos  efeitos  de  sulfato  de  magnésio  e  da  dexmedetomidina  sobre  a
qualidade  da  visibilidade  em  cirurgia  endoscópica  sinusal:  estudo  clínico  randomizado
Resumo
Justiﬁcativa  e  objetivo:  Uma  quantidade,  mesmo  pequena,  de  sangramento  durante  a  cirurgia
endoscópica pode  alterar  o  campo  endoscópico  e  diﬁcultar  o  procedimento.  Várias  técnicas,
incluindo  hipotensão  induzida,  podem  minimizar  o  sangramento  durante  a  cirurgia  endoscópica.
O  objetivo  deste  estudo  foi  comparar  a  qualidade  da  visibilidade  cirúrgica,  os  parâmetros
hemodinâmicos, a  dor  no  período  pós-operatório  e  outros  efeitos  do  sulfato  de  magnésio,  um
agente  hipotensor,  com  os  da  dexmedetomidina,  inicialmente  desenvolvida  para  sedac¸ão  em
curto  prazo  em  unidade  de  terapia  intensiva,  mas  que  também  é  um  sedativo  agonista  alfa-2.
Métodos:  Foram  alocados  60  pacientes  entre  18  e  45  anos  em  dois  grupos:  Grupo  M  (magnésio)
e Grupo  D  (dexmedetomidina).  No  Grupo  M,  sulfato  de  magnésio  foi  administrado  pré-induc¸ão
a uma  dose  de  carga  de  50  mg  kg−1 por  10  minutos  e  mantida  com  15  mg  kg−1 h−1;  no  Grupo
D, dexmedetomidina  foi  administrada  a  uma  dose  de  1  mcg  kg−1 10  minutos  antes  da  induc¸ão
e mantida  com  0,6  mcg  kg−1 h−1.  No  período  intraoperatório,  foram  registrados  os  parâmetros
hemodinâmicos e  respiratórios  e  a  avaliac¸ão  do  campo  cirúrgico  com  uma  escala  de  seis  pontos.
Durante  o  período  pós-operatório  foram  registrados  os  valores  da  escala  numérica  de  11  pontos
para  avaliar  a  dor,  a  escala  de  sedac¸ão  de  Ramsay,  a  escala  de  avaliac¸ão  de  náusea/vômito,  o
perﬁl  dos  efeitos  adversos  e  pruridos.
Resultados:  O  Grupo  D  apresentou  reduc¸ão  signiﬁcativa  da  frequência  cardíaca  e  do  escore
na escala  de  avaliac¸ão  do  campo  cirúrgico  intraoperatório.  A  média  do  tempo  cirúrgico  foi
de  50  minutos  e  o  Grupo  M  apresentou  um  número  maior  de  cirurgias  prolongadas.  Não  houve
diferenc¸a signiﬁcativa  em  outros  parâmetros.
Conclusão:  Por  causa  da  reduc¸ão  da  taxa  de  sangramento  e  da  frequência  cardíaca  em  cirurgia
endoscópica e  dos  impactos  positivos  sobre  a  durac¸ão  da  cirurgia,  consideramos  dexmedeto-
midina  como  melhor  opc¸ão  que  o  sulfato  de  magnésio.
©  2014  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  
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Endoscopic  sinus  surgery  (ESS)  is  a  form  of  surgical  interven-
tion in  which  surgical  visualization  may  diminish  completely
with only  a  small  amount  of  bleeding.1 This  surgery  is  done
under endoscopic  magniﬁcation  in  a  narrow  area  where
manipulation is  difﬁcult.
Therefore, hypotensive  bleeding  control  during  the  oper-
ation may  help  to  increase  surgical  visualization.  Different
anaesthetic techniques  and  drugs  are  being  explored  and
tested to  help  to  solve  this  problem.2-4 Magnesium  is  one
drug used  for  this  purpose,  and  its  positive  effects  on
the control  of  postoperative  bleeding  have  been  clearly
deﬁned.5,6 Magnesium  is  an  N-methyl-d-aspartate  (NMDA)
receptor antagonist  that  reduces  the  need  for  analgesic  and
sedative drugs.  Dexmedetomidine  is  also  an  alpha  2  ago-
nist; it  has  sedative,  amnestic,  and  analgesic  properties.7
Additionally,  it  has  a  decongestant  effect  and  induces
hypotension in  tympanoplasty  surgeries.8,9 Dexmedetomi-
dine has  been  also  used  in  ESS  patients  under  local
anesthesia,10,11 as  well  as  in  septoplasty  and  tympanoplasty
patients under  general  anaesthesia;  it  has  been  stated  that
it decreases  the  bleeding  score  and  reduces  the  required
amount of  fentanyl.12
Therefore,  in  our  study  we  compared  the  effects  of  mag-
nesium and  dexmedetomidine,  which  are  used  during  ESS
in patients  under  general  anaesthesia,  primarily  on  surgi-
cal vision  quality  and  on  haemodynamics  and  postoperative
analgesia.
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fter  the  approval  of  the  University  of  Abant  Izzet  Baysal
linical Research  Ethics  Committee,  document  number
011/97, we  enrolled  60  patients  of  the  American  Society
f Anesthesiologists  (ASA)  risk  classiﬁcation  I--II  accord-
ng to  the  pre-anaesthetic  evaluation,  ranging  from  18  to
5 years  of  age  who  were  scheduled  to  have  an  elec-
ive functional  ESS  operation.  The  patients  were  randomly
ivided into  two  groups  of  30  people:  the  magnesium
roup (Group  M)  and  the  dexmedetomidine  group  (Group
). The  control  group  without  hypotensive  drugs  was  not
sed due  to  ethical  concerns,  and  the  two  agents  were
ompared. Patients  who  were  allergic  to  any  of  the  drugs
hat would  be  used  in  the  study,  those  who  had  hyper-
agnesaemia, were  opioid-dependent,  had  severe  cardiac,
enal, neurological,  and  liver  diseases,  and  had  a  history
f postoperative  nausea/vomiting  were  excluded  from  the
tudy.
In the  preoperative  evaluation,  all  patients  were  asked
o provide  oral  and  written  informed  consent  for  the  anaes-
hesia and  research;  those  who  accepted  and  signed  were
ncluded in  the  study.  The  patients  were  informed  about
he method  of  anaesthesia,  and  their  adaptation  to  the
tudy was  implemented  by  explaining  the  11-unit  Numeri-
Este é um artigo Open Access sob a licença de CC BY-NC-NDal Pain  Scoring  (NPS11)  Scale,  Ramsay  Sedation  Score,  and
ausea/vomiting scale.  These  parameters  were  recorded
mmediately after  surgery  and  then  thereafter  at  intervals
f 5  min.
4 A.  Akkaya  et  al.
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Table  1  Intraoperative  surgical  ﬁeld  evaluation  scale:
IOSFE: Boezaart  Scale.
No  bleeding  0
Slight  bleeding  --  no  suctioning  of  blood  required 1
Slight  bleeding  --  occasional  suctioning  required.
Surgical  ﬁeld  not  threatened
2
Slight bleeding  --  frequent  suctioning  required.
Bleeding  threatens  surgical  ﬁeld  a  few  seconds
after suction  is  removed
3
Moderate bleeding  --  frequent  suctioning
required.  Bleeding  threatens  surgical  ﬁeld
directly  after  suction  is  removed
4
Severe bleeding  -- constant  suctioning  required.
Bleeding  appears  faster  than  can  be  removed
5
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Prior  to  surgery,  the  patients  were  taken  to  the
reoperative preparation  room,  and  0.5  mg  atropine  sul-
hate (Atropine  ampoule,  0.5  mg  mL−1,  Biofarma,  Istanbul,
urkey) and  midazolam  0.1  mg  kg−1 (Dormicum  1  mg  mL−1,
oche müstahzarlari  san,  Istanbul,  Turkey)  were  applied
ntramuscularly 30  min  before  the  patients  were  taken  to
he operating  table.
In the  operating  room,  all  patients  who  were  given  O2
t  2  L min−1 with  a  nasal  cannula  received  electrocardio-
ram monitoring,  and  the  heart  rate  (HR),  mean  arterial
ressure (MAP),  peripheral  oxygen  saturation  (SpO2),  and
espiratory rate  (RR)  were  also  monitored  (Drager  Inﬁnity
L monitor).  Anaesthesia  was  induced  with  50  mcg  fentanyl
fentanyl citrate  ﬂakon  50  mcg  mL−1,  Meditera  Ltd.  Istan-
ul, Turkey),  1.5  mg  kg−1 propofol  (Propofol  1%  Fresenius,
stanbul, Turkey),  and  0.5  mg  kg−1 rocuronium  bromides
Esmeron 5  mg  ﬂakon,  Organon,  Istanbul).  Anaesthesia  was
aintained with  50%  O2,  50%  N2O,  and  1.5%  sevoﬂurane
Sevorane, Abbott,  Istanbul,  Turkey).  Muscle  relaxation  was
aintained with  0.15  mg  kg−1 rocuronium  bromide  and  used
hen needed.
Patients were  randomly  divided  into  two  equal  groups
y the  closed  card  method  by  a  supervisor  who  did  not
articipate in  the  other  sequences  of  the  study.  In  Group
, the  infusion  of  magnesium  sulphate  was  started  before
nduction at  a  loading  dose  of  50  mg  kg−1 for  10  min,  and
hen was  sustained  throughout  the  operation  at  a  main-
enance dose  of  15  mg  kg−1 h−1 intravenously.  In  Group  D,
efore induction,  1  mcg  kg−1 for  10  min  of  dexmedetomi-
ine was  given  by  infusion,  and  during  the  operation,  the
aintenance dose  of  0.6  mcg  kg−1 h−1 was  administered.
fter induction,  the  operation  table  was  positioned  in  a
0◦ reverse  Trendelenburg  position,  and  1  mL  of  local  anaes-
hetic was  applied  to  the  pterygopalatine  fossa  (Lidocaine
ydrochloride 20  mg  mL−1,  Epinephrine  base  0.0125  mg  mL−1
Jetokain  ampoule  2  mL,  Adeka,  Istanbul)).  The  intubation
ube was  ﬁxed  with  adhesive  tape  around  the  mouth.  Pos-
tive end-expiratory  pressure  (PEEP)  was  limited  to  1  cm
2O.  The  total  duration  of  the  operation  was  recorded.
t the  end  of  surgery,  the  muscle  relaxation  effect  was
ntagonized with  the  use  of  atropine  0.01  mg  kg−1 and
eostigmine 0.05  mg  kg−1.  Surgical  team,  postoperative
easurement teams  (anesthesiology  assistants)  and  patients
ere unaware  of  the  drugs  that  had  been  used.
Patients  were  followed  up  prior  to  intubation  and  also
, 2,  3,  5,  10,  15,  20,  30,  40,  50,  60,  70,  80,  and  90  min
fter intubation  in  terms  of  MAP,  RR,  SpO2,  nausea/vomiting,
tching, adverse  effects,  complications  of  anaesthesia,  and
urgical complications.  At  the  end  of  the  operation,  when
he body  temperature  of  the  patients  was  >36  degrees  Cel-
ius and  their  modiﬁed  Aldrete  score  was  =  9,  they  were
xtubated, and  postoperative  follow-up  was  done.  Patients
ere evaluated  before  extubation  and  0,  5,  10,  20,  30,
0 min  after  extubation  in  terms  of  MAP,  RR,  SpO2, nau-
ea/vomiting, itching,  adverse  effects,  complications  of
naesthesia, and  surgical  complications.  In  the  postop-
rative period,  4-point  nausea/vomiting  scale  for  nausea,
1-unit Numerical  Pain  Scoring  (NPS11)13 for  pain  evaluation,
amsay Sedation  Scale  for  the  sedation  degree,  and  Intra
perative Surgical  Field  Evaluation  (IOSFE)  Scale14 to  mea-
ure bleeding  at  the  surgical  area  were  employed.  This  scale
as used  because  any  blood  aspirated  from  the  bleeding
T
p
vby  suction.  Surgical  ﬁeld  severely  threatened
and  surgery  not  possible.
rea  mixes  with  the  washing  solution,  and  the  amount  of  liq-
id escaping  to  the  stomach  greatly  varies  from  patient  to
atient and  prevents  mathematical  calculations  from  being
one on  the  basis  of  the  liquid  accumulated  in  the  aspirator
lone. Table  1  shows  the  IOSFE  scale.  Nausea  and  vomi-
ing scale  was  described  as  follows:  no  nausea/vomiting,
ild nausea/vomiting  (treatment  not  indicated),  moderate
ausea/vomiting (treatment  indicated)  and  severe  nau-
ea/vomiting (resistive  to  treatment).
In  case  of  intraoperative  anaesthetic  depth  failure,
 mcg  kg−1 of  fentanyl  (fentanyl  citrate,  ﬂakon  50  mcg  mL−1,
editera Ltd.,  Istanbul,  Turkey)  intravenously  (IV)  was  avail-
ble.
For postoperative  analgesia,  1  mg  kg−1 of  pethidine  HCL
as given  intramuscularly  (IM)  (Aldolan  ampoule  100  mg,
 mL,  Liba  Ilac  Sanayi)  when  the  NPS11  value  was  4  or
ore; for  nausea/vomiting,  0.25  mg  kg−1 IV  of  metoclo-
ramide (Avil  ampoule,  50  mg,  2  mL,  Istanbul,  Turkey)  was
n hand.
Statistical analysis  was  done  via  the  SPSS  11.5  statistical
ackage (SPSS,  Chicago,  IL,  USA).  For  the  IOSFE  scale,  the
ann--Whitney U  test  was  used  to  compare  the  mean  values
etween groups.  Calculations  were  performed  with  indepen-
ent t tests  for  the  average  of  numerical  data  distributed
ormally and  with  the  Chi-square  test  using  a  cross-table
or the  frequency  analysis  of  data,  such  as  the  percentage
f males  vs.  females.  When  calculating  the  number  of  par-
icipants to  include  in  the  study,  the  following  parameters
ere used:  the  IOSFE  Scale,  which  was  the  primary  output,
eeded to  have  an  average  value  of  2  or  3  between  similar
tudy groups;  the  approximate  standard  deviation  should  be
lose to  1.1;  the  alpha  error  margin  should  be  0.05  with
he consideration  of  bipolar  probability  and  abnormal  logis-
ic character  of  the  distribution;  the  power  value  (1-beta)
eeded to  be  0.95;  and  the  sample  size  was  calculated  as  30
er group.
esultshe  demographic  data  and  the  operation  duration  of  the
atients included  in  the  study  are  presented  as  an  average
alue in  Table  2  and  there  is  no  statistical  signiﬁcance.  The
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Table  2  The  average  value  of  patients’  age,  weight,  and  duration  of  operation.
Each  group’s  n  =  30  Age  Weight  Duration  of  Op.
Mg
Mean  ±  SD  42.9  ±  15.1  74.9  ±  12.1  50.2  ±  18.6
% 95  CI  37.3--48.5  70.4--79.4  43.2--57.1
Dex
Mean  ±  SD  42.5  ±  16.1  74.9  ±  13.4  51.0  ±  14.8
% 95  CI  36.5--48.6  69.9--79.9  45.5--56.5
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DSD, standard deviation; CI, conﬁdence interval.
female/male  ratio  was  8/22  in  Group  M  and  12/18  in  Group
D, and  there  was  no  signiﬁcant  difference  between  the  two
(p =  0.273).
Mean  arterial  pressure  (MAP)  analysis  revealed  that  the
blood pressure  was  lower  for  a  short  period  of  time  in  Group
D at  the  35th  and  65th  min.  The  p-values  of  the  minutes
at which  a  signiﬁcant  difference  was  observed  are  given  in
Fig. 1.  The  data  shown  at  the  left  side  of  the  dashed  line
indicate that  the  ﬁrst  88%  of  the  cases  were  completed  in
less than  70  min.
No difference  was  detected  during  and  after  the  oper-
ation in  the  values  of  SpO2 and  respiratory  rates,  or
from extubation  until  the  ﬁrst  postoperative  hour  in
the values  of  the  nausea/vomiting  scale  and  the  NPS11.
None of  the  patients  needed  intraoperative  fentanyl
or postoperative  analgesic,  anti-emetics,  or  anti-pruritic
agents.
In the  analysis  of  HR,  from  the  pre-intubation  period  until
the 20th  min  and  at  the  35th,  40th,  and  45th  min,  it  was
observed that  the  HR  was  signiﬁcantly  slower  in  Group  D.  As
shown in  Fig.  2,  the  course  of  the  HR  values  at  the  following
minutes is  presented  with  p-values  and  the  line,  indicating
that 88%  of  the  cases  were  completed.
I
o
t
a
–5 0
120
100
80
60
40
20
0
5 10 15 20 25 30 35 40
Figure  1  The  95-min  course  of  MAP  values  and  the  border  line  ind
than  70  min;  p-values  of  the  difference  observed  at  the  35th  and  65It was  noted  that  the  conﬁdence  interval  of  the  surgery
uration was  wider  in  Group  D.
The  longest  case  was  90  min  in  Group  M,  and  the  short-
st case  was  20  min,  of  which  there  was  one  case  in  both
he groups.  Six  cases  in  Group  M  and  one  in  Group  D  took
onger than  70  min.  When  these  frequencies  were  compared,
 signiﬁcant  difference  in  favour  of  Group  D  was  observed
p =  0.044).  The  percentage  of  the  cases  that  lasted  more
han 70  min  was  signiﬁcantly  higher  in  Group  M  than  in  Group
.
The target  output  of  our  study  was  the  IOSFE  scale,  and
t had  a signiﬁcantly  low  level  statistically  in  Group  D  at
he 5th,  10th,  20th,  30th,  45th,  and  60th  min,  as  shown  in
able 3.  In  both  groups,  the  international  normalized  ratio
INR) values  of  patients  were  lower  than  1.33.
iscussionn  our  study,  no  signiﬁcant  difference  was  found  in  terms
f age,  weight,  gender,  and  duration  of  operation  between
he two  groups.  For  HR,  signiﬁcant  and  meaningful  deceler-
tions were  observed  in  Group  D  from  the  operation’s  start
Cases of %88 in the left side
of the  dashed line
Minute
Mg
Dex
45 50 55 60 65 70 75 80 85 90
icating  that  the  ﬁrst  88%  of  the  cases  were  completed  in  less
th  min  were  0.005  and  0.023,  respectively.
410  A.  Akkaya  et  al.
Table  3  The  IOSFE  Scale:  Mean  ±  SD,  %  95  CI  and  P-values.
Time  05  10  15  20  30  45  50  60
Mg
Mean  ±  SD  2  ±  1.  2.5  ±  1  2.6  ±  1  2.5  ±  0.5  2.3  ±  0.5  2.5  ±  0.5  2.5  ±  0.5  2.7  ±  0.6
% 95  CI  1.2--2.7  1.8--3.1  1.9--3.3  2.1--2.8  2.0--2.7  2.1--2.8  2.1--2.9  2.3--3.2
Dex
Mean  ±  SD  1.3  ±  0.6  1.4  ±  0.8  1.5  ±  0.8  1.8  ±  0.9  1.7  ±  0.9  1.7  ±  0.9  1.8  ±  0.8  1.5  ±  1
% 95  CI  0.9--1.7  0.9--1.8  1.0--2.0  1.2--2.3  1.2--2.2  1.2--2.2  1.5--2.3  1--2.1
p  0.001  0.000  0.005  0.024  0.001  0.000  0.001  0.002
SD, standard deviation; CI, conﬁdence interval.
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0ntil  the  45th  min.  The  decelerations  lasted  for  a total  of
5 min.  Considering  that  the  average  duration  of  the  surgical
rocedure was  50  min,  it  can  be  inferred  that  dexmedetomi-
ine provided  a  notable  decrease  in  HR  during  the  majority
f the  surgery  compared  to  magnesium.  The  positive  effects
f a  decrease  in  HR  on  bleeding  are  known.2 When  the  MAP
as compared,  no  signiﬁcant  difference  between  the  two
rugs in  terms  of  blood  pressure  was  identiﬁed  due  to  the
bservation of  decreases  occurring  only  at  the  35th  and
5th min,  the  total  decrease  time  being  10  min,  and  this
ime remaining  shorter  in  regard  to  average  operation  time.
We  did  not  use  a  control  group  in  the  study  because
e considered  it  unethical  not  to  try  to  control  bleeding
n the  surgical  ﬁeld  without  active  precautions,  such  as
eliberate hypotension  to  reduce  bleeding;  also  the  surgi-
al team  demanded.  Pre-  and  postoperative  haemoglobin
alues were  not  compared  in  this  study  because  the  blood
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igure  2  The  Course  of  Heart  Rate  (HR)  Values  During  the  Opera
bserved:  before  intubation,  after  intubation,  0,  5,  10,  20,  35,  40,  a
.007,  0.032,  0.028,  0.032,  and  0.034.ost  during  ESS  is  low  enough  not  to  expect  any  signiﬁcant
aboratory measurement  differences  every  time,  although
ven small  amounts  restrict  surgical  vision  in  a  narrow  oper-
tive ﬁeld.11,15,16 While  the  total  blood  lost  does  not  require
ransfusion (100--300  mL),  numerous  techniques  to  reduce
leeding have  been  developed  due  to  the  loss  of  vision  in
he surgical  area  when  blood  is  present.5,11,17--21 Some  of
hese are  steroids,  tranexamic  acid,  deliberate  hypotension
gents, sevoﬂurane,  total  intravenous  anaesthesia  (TIVA),
nd various  patient  positions.  The  literature  has  shown  that
 lack  of  vision  in  the  surgical  ﬁeld  extends  the  duration  of
he operation  and  increases  the  rate  of  complications.22--25 In
he majority  of  publications  that  have  investigated  the  issue,
urgical ﬁeld  clarity  outranked  the  amount  of  bleeding.
ther studies11 have  been  unable  to  ﬁnd  a  signiﬁcant  differ-
nce between  postoperative  haemoglobin  values  and  have
dentiﬁed differences  in  surgical  ﬁeld  evaluation;  similarly,
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RDexmedetomidine  vs  magnesium  in  endoscopic  sinus  surgery
studies  have  found  different  levels  of  bleeding  between
two groups  but  have  indicated  that  this  difference  does  not
affect  surgical  vision.23 Not  all  blood  leaks  that  occur  during
endoscopic sinus  surgery  are  observed  in  the  front  part  of
the surgical  area;  the  leaks  can  sometimes  ﬁnd  their  way
outside of  the  visible  ﬁeld  and  reach  the  pharynx.  This  sit-
uation explains  why  the  amount  of  haemorrhage  and  the
surgical vision  quality  are  sometimes  irrelevant.
In  our  study,  no  statistical  difference  was  found  in  terms
of the  mean  duration  of  surgery  (p  =  0.74).  However,  96.6%  of
the cases  in  Group  D  were  completed  before  70  min,  whereas
in Group  M,  this  percentage  was  80%.  When  the  distribution
of the  cases  of  both  groups  that  lasted  more  than  70  min
was compared  with  the  total  group  number  via  frequency
analysis, the  probability  value  was  p  =  0.044.  In  other  words,
in Group  M,  more  patients  required  a  prolonged  surgery.  This
observation supported  the  limitation  of  vision  in  the  surgical
ﬁeld.
In many  studies  that  have  researched  the  drugs  used  to
reduce bleeding  in  endoscopic  sinus  surgery,  the  effects  of
the aforementioned  drugs  on  the  need  for  postoperative
analgesics have  also  been  investigated  and  presented  as
a secondary  outcome.  Some  studies  have  argued  that  the
pain was  less  in  these  surgeries.26 In  our  study,  regardless
of the  group,  all  of  the  NPS11  values  were  =  4,  which  is
the recommended  value  to  provide  preemptive  analgesics  in
the postoperative  period,  so  that  point  was  never  reached.
When the  NPS11  values  were  analyzed,  no  signiﬁcant  differ-
ence was  found  at  any  of  the  measurement  points  in  the  ﬁrst
postoperative hour.
Some publications  suggest  that  TIVA  is  preferable
to inhalation  anaesthesia  in  endoscopic  sinus  surgery.27
Whether  they  ﬁt  the  deﬁnition  of  TIVA  or  not,  the  impor-
tance of  evoked  hypotension  provided  by  some  intravenous
agents is  obvious.20,21,28 Propofol  and  remifentanil  are  only
some of  them.
Magnesium is  an  agent  that  has  been  indicated  to
decrease MAP  under  general  anaesthesia  and  reduce  the  HR,
as well  as  to  lessen  the  need  for  anaesthetic  substance  and
to reduce  bleeding.  It  also  makes  a  positive  contribution  to
the postoperative  pain  score.29
Magnesium  also  does  not  cause  reﬂex  tachycardia
when used  as  an  intraoperative  hypotensive  agent,  does
not produce  reﬂex  hypertension,  and  does  not  lower
cardiac output.30 In  a  randomized,  double-blind,  and
placebo-controlled clinical  trial  conducted  with  60  patients
scheduled for  endoscopic  surgery,  they  found  a  statisti-
cally signiﬁcant  lower  HR  and  MAP  in  the  magnesium  group
than they  did  in  their  control  group.5 Also,  the  quality  of
vision of  the  surgical  ﬁeld  was  higher  in  the  magnesium
group. In  the  same  study,  the  operative  time  in  the  control
group was  signiﬁcantly  prolonged,  whereas  in  the  magne-
sium group,  the  duration  of  anaesthesia  had  been  prolonged
depending on  the  postoperative  awakening.  However,  in
operations that  require  general  anaesthesia,  a  partially
disadvantageous feature  of  magnesium  is  that  it  reduces
acetylcholine release31 and  extends  the  effects  of  neuro-
muscular blockers;32 some  publications  have  also  indicated
different effects  on  clotting  mechanisms.33
Dexmedetomidine  is  a  drug  that  is  not  yet  approved  in  the
United States  by  the  Food  and  Drug  Administration  (FDA)  for
use under  general  anaesthesia.  In  one  retrospective  study,411
134  patients  who  received  dexmedetomidine  in  the  periop-
rative period  were  examined,  and  favourable  results  were
eported.34 Dexmedetomidine  had  been  used  both  as  an
djuvant35 to  regional  anaesthesia,  an  intravenous  addition
o eliminate  negative  effects  of  intubation36,37 in  general
naesthesia, and  as  a method  to  provide  controlled  hypoten-
ion.
Jalonen and  his  colleagues  had  used  dexmedetomidine
s an  anaesthetic  adjuvant  in  open  heart  surgery  in  coro-
ary artery  grafting,  and  they  found  that  the  hyperdynamic
esponse to  surgery  and  anaesthesia  was  signiﬁcantly  sup-
ressed in  the  dexmedetomidine  group  compared  to  the
ontrol group  in  an  80-patient  study.38 Guven  et  al.11 inves-
igated the  effectiveness  of  dexmedetomidine  on  bleeding,
aemodynamic parameters,  and  postoperative  analgesia  in
heir study  that  included  over  40  patients  scheduled  for
unctional endoscopic  sinus  surgery  in  randomized,  prospec-
ive, and  control  groups.  No  difference  was  found  between
re- and  postoperative  haemoglobin  values.  However,  they
eported a  signiﬁcant  difference  in  the  bleeding  score
p =  0.019).  In  our  study,  signiﬁcant  differences  were  found
n HR  as  well  as  surgical  area  evaluation  scale  in  the  Group
 compared  to  Group  M.
In  ESS,  agents  providing  controlled  hypotension  and  TIVA
ave emerged  with  the  purpose  of  surgical  ﬁeld  clarity.
herefore, we  tested  the  superiority  of  two  agents,  mag-
esium and  dexmedetomidine,  against  each  other  for  this
urpose.
This topic  is  a  subject  that  is  still  of  interest,  and  another
ntravenous agent,  remifentanil,  is  also  increasingly  being
sed.39 In  the  future,  we  believe  that  the  number  of  effec-
ive and  reliable  drugs  for  ESS  will  continue  to  develop,  but
he interest  will  be  clariﬁed  to  concentrate  on  innovative
ethods.
The results  obtained  from  our  research  have  shown  that
exmedetomidine provided  better  visual  quality  of  the  sur-
ical ﬁeld  compared  to  magnesium  when  used  in  ESS  patients
nder general  anaesthesia.  As  a  result,  we  believe  that
n endoscopic  sinus  surgeries,  dexmedetomidine  is  a  good
lternative to  magnesium  due  to  its  higher  reducing  effect
n bleeding  in  the  surgical  ﬁeld  and  the  greater  suppression
f HR  compared  to  magnesium.
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